T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis.

Autor:	Briukhovetska, Daria1 (AUTHOR), Suarez-Gosalvez, Javier1 (AUTHOR), Voigt, Cornelia1 (AUTHOR), Markota, Anamarija1 (AUTHOR), Giannou, Anastasios D.2,3 (AUTHOR), Schübel, Maryam1 (AUTHOR), Jobst, Jakob1 (AUTHOR), Zhang, Tao2 (AUTHOR), Dörr, Janina1 (AUTHOR), Märkl, Florian1 (AUTHOR), Majed, Lina1 (AUTHOR), Müller, Philipp Jie1 (AUTHOR), May, Peter1 (AUTHOR), Gottschlich, Adrian1 (AUTHOR), Tokarew, Nicholas1 (AUTHOR), Lücke, Jöran2,3 (AUTHOR), Oner, Arman1 (AUTHOR), Schwerdtfeger, Melanie1 (AUTHOR), Andreu-Sanz, David1 (AUTHOR), Grünmeier, Ruth1 (AUTHOR)
Zdroj:	Immunity (10747613). Jan2023, Vol. 56 Issue 1, p143-143. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu